APLS vs. ULTA
Compare and contrast key facts about Apellis Pharmaceuticals, Inc. (APLS) and Ulta Beauty, Inc. (ULTA).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: APLS or ULTA.
Correlation
The correlation between APLS and ULTA is 0.46, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
APLS vs. ULTA - Performance Comparison
Key characteristics
APLS:
-1.08
ULTA:
-0.00
APLS:
-1.98
ULTA:
0.23
APLS:
0.76
ULTA:
1.03
APLS:
-0.78
ULTA:
-0.04
APLS:
-1.99
ULTA:
-0.14
APLS:
31.96%
ULTA:
12.00%
APLS:
53.71%
ULTA:
38.56%
APLS:
-81.38%
ULTA:
-87.89%
APLS:
-80.91%
ULTA:
-31.55%
Fundamentals
APLS:
$2.56B
ULTA:
$17.87B
APLS:
-$1.60
ULTA:
$25.33
APLS:
3.27
ULTA:
1.58
APLS:
11.19
ULTA:
7.18
APLS:
$609.04M
ULTA:
$8.57B
APLS:
$511.08M
ULTA:
$3.32B
APLS:
-$95.69M
ULTA:
$1.31B
Returns By Period
In the year-to-date period, APLS achieves a -44.19% return, which is significantly lower than ULTA's -10.74% return.
APLS
-44.19%
-4.76%
-38.03%
-57.90%
-10.82%
N/A
ULTA
-10.74%
18.36%
-1.28%
-0.06%
11.07%
9.69%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
APLS vs. ULTA — Risk-Adjusted Performance Rank
APLS
ULTA
APLS vs. ULTA - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Apellis Pharmaceuticals, Inc. (APLS) and Ulta Beauty, Inc. (ULTA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
APLS vs. ULTA - Dividend Comparison
Neither APLS nor ULTA has paid dividends to shareholders.
Drawdowns
APLS vs. ULTA - Drawdown Comparison
The maximum APLS drawdown since its inception was -81.38%, smaller than the maximum ULTA drawdown of -87.89%. Use the drawdown chart below to compare losses from any high point for APLS and ULTA. For additional features, visit the drawdowns tool.
Volatility
APLS vs. ULTA - Volatility Comparison
Apellis Pharmaceuticals, Inc. (APLS) has a higher volatility of 14.79% compared to Ulta Beauty, Inc. (ULTA) at 12.55%. This indicates that APLS's price experiences larger fluctuations and is considered to be riskier than ULTA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
APLS vs. ULTA - Financials Comparison
This section allows you to compare key financial metrics between Apellis Pharmaceuticals, Inc. and Ulta Beauty, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
APLS vs. ULTA - Profitability Comparison
APLS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Apellis Pharmaceuticals, Inc. reported a gross profit of 171.67M and revenue of 212.53M. Therefore, the gross margin over that period was 80.8%.
ULTA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Ulta Beauty, Inc. reported a gross profit of 1.33B and revenue of 3.49B. Therefore, the gross margin over that period was 38.2%.
APLS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Apellis Pharmaceuticals, Inc. reported an operating income of -26.16M and revenue of 212.53M, resulting in an operating margin of -12.3%.
ULTA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Ulta Beauty, Inc. reported an operating income of 516.32M and revenue of 3.49B, resulting in an operating margin of 14.8%.
APLS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Apellis Pharmaceuticals, Inc. reported a net income of -36.35M and revenue of 212.53M, resulting in a net margin of -17.1%.
ULTA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Ulta Beauty, Inc. reported a net income of 393.27M and revenue of 3.49B, resulting in a net margin of 11.3%.